Envoy Medical EBITDA Growth & History (COCH)

Envoy Medical's calculated EBITDA was −$22.0M for fiscal 2025.

View full Envoy Medical company overview

Envoy Medical annual ebitda history

Envoy Medical annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20252025-12-31−$22.0M−$2.9M
20242024-12-31−$19.1M−$857,000
20232023-12-31−$18.2M−$9.6M
20222022-12-31−$8.6M

Envoy Medical ebitda trends

Between the periods ended 2022-12-31 and 2025-12-31, Envoy Medical's ebitda decreased from −$8.6M to −$22.0M, a change of −$13.3M. The latest reported quarter, Q2 2026, shows −$5.5M.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Envoy Medical source filings ↗

Community posts

It’s quiet here.

No posts about COCH yet. Start the conversation.

Write the first post